Sign in
PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
Journal article   Open access  Peer reviewed

PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE

M. Hiligsmann, S. Williams, L. Fitzpatrick, S. Silverman, R.J. Weiss and J.Y. Reginster
Value in health, Vol.22, pp.S243-S243
05/2019
url
https://doi.org/10.1016/j.jval.2019.04.1136View
Published (Version of record) Open

Metrics

1 Record Views

Details